Brief: EyeGate Enters Into Agreement For $8 Mln Private Placement
Jan 6 (Reuters) - EyeGate Pharmaceuticals Inc EYEG.O :
* EYEGATE ENTERS INTO AGREEMENT FOR $8.0 MILLION PRIVATE
PLACEMENT
* EYEGATE PHARMACEUTICALS INC - EXPECTS TO USE NET PROCEEDS
FROM
PRIVATE PLACEMENT TO SUPPORT ITS OPERATIONS
* EYEGATE PHARMACEUTICALS - TO PURCHASE AN AGGREGATE OF 1.5
MILLION SHARES OF COMMON STOCK, WITH A COMBINED PURCHASE PRICE
$5.225 PER SHARE AND WARRANT
Source text for Eikon: ID:nGNX8PrVMz
Further company coverage: EYEG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing